av/tme-pharma-nv--big.svg

COM:TMEPHARMA

TME Pharma N.V.

  • Stock

EUR

Last Close

0.15

25/11 09:23

Market Cap

6.05M

Beta: -

Volume Today

744.63K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
25.50K
-
6.50K
74.51%
average payables
2.83M
-
2.30M
18.78%
1.35M
41.36%
1.32M
1.74%
1.29M
2.91%
1.50M
16.65%
2.02M
34.64%
1.97M
2.67%
average receivables
82K
-
81.50K
0.61%
book value per share
-311.32
-
-350.67
12.64%
-154.79
55.86%
-184.22
19.02%
-65.24
64.59%
-16.52
74.68%
23.83
244.26%
6.84
71.28%
capex per share
-2.34
-
-0.40
82.98%
-1.31
228.54%
-0.09
92.81%
-0.23
140.15%
-0.14
36.61%
-0.12
15.95%
-0.02
82.40%
capex to depreciation
-0.17
-
-0.04
78.22%
-0.06
68.31%
-0.07
11.66%
-0.39
467.39%
-0.34
13.00%
-0.62
81.85%
-0.21
65.73%
-0.23
7.61%
capex to operating cash flow
0.00
-
0.00
84.27%
0.00
293.62%
0.00
79.79%
0.00
376.66%
0.00
65.91%
0.01
99.98%
0.00
84.85%
0.00
52.94%
capex to revenue
-1.88
-
-0.19
90.10%
-0.25
35.99%
cash per share
76.15
-
212.04
178.45%
148.11
30.15%
32.49
78.06%
108.52
233.97%
12.41
88.56%
31.84
156.55%
14.37
54.86%
days of inventory on hand
3.77
-
1.80
52.37%
days payables outstanding
246.61
-
438.50
77.81%
355.74
18.87%
484.51
36.20%
511.07
5.48%
424.24
16.99%
days sales outstanding
14.60
-
1.38K
9,376.74%
debt to assets
2.04
-
1.47
28.12%
1.03
30.26%
2.80
173.54%
1.06
62.21%
0.07
93.79%
0.01
90.16%
0.25
3,756.98%
0.78
212.10%
debt to equity
-1.01
-
-1.26
24.76%
-1.19
6.09%
-0.67
43.85%
-1.84
176.92%
-0.06
96.65%
0.01
114.47%
0.54
5,938.62%
-3.21
694.40%
dividend yield
earnings yield
-0.32
-
-0.37
16.70%
-0.31
18.33%
-0.41
33.02%
-2.64
551.83%
-0.13
94.99%
-0.57
331.55%
-0.94
63.59%
enterprise value
47.91M
-
47.90M
0.01%
35.96M
24.93%
15.25M
57.58%
4.56M
70.14%
5.22M
14.65%
7.95M
52.22%
8.42M
5.96%
-548K
106.50%
enterprise value over ebitda
-3.72
-
-3.40
8.65%
-4.45
31.04%
-4.14
6.92%
-1.15
72.21%
-6.45
459.96%
-1.50
76.68%
-0.65
56.50%
0.05
107.20%
ev to operating cash flow
-3.85
-
-3.55
7.60%
-4.00
12.57%
-3.60
9.98%
-1.14
68.37%
-1.22
7.00%
-1.52
24.89%
-0.68
55.29%
0.05
106.63%
ev to sales
1.92K
-
1.11K
41.87%
433.25
61.11%
free cash flow per share
-623.65
-
-672.72
7.87%
-562.48
16.39%
-199.62
64.51%
-100.75
49.53%
-38.55
61.73%
-16.26
57.81%
-18.78
15.49%
free cash flow yield
-0.29
-
-0.31
7.87%
-0.26
18.25%
-0.32
24.87%
-0.99
209.27%
-0.66
32.94%
-0.29
56.31%
-0.80
177.38%
graham net net
-388.28
-
-433.46
11.64%
-185.87
57.12%
-195.81
5.35%
-70.55
63.97%
-19.73
72.04%
22.71
215.12%
6.39
71.85%
graham number
2.20K
-
2.52K
14.65%
1.53K
39.28%
1.03K
32.92%
629.29
38.62%
53.55
91.49%
131.30
145.18%
58.07
55.77%
income quality
0.90
-
0.84
7.42%
0.84
0.26%
0.79
6.21%
0.37
52.62%
4.98
1,237.76%
0.50
89.93%
0.86
70.65%
0.80
6.29%
intangibles to total assets
0.03
-
0.01
72.68%
0.00
37.28%
0.01
10.30%
0.00
79.44%
0.00
108.68%
0.00
83.74%
0.00
9.07%
0.00
86.38%
0
100%
interest coverage
-20.83
-
-11.46
44.99%
-4.04
64.72%
-2.82
30.27%
-0.65
77.08%
-1.32K
203,553.03%
-1.14
99.91%
-8.82
672.94%
-3.54
59.89%
-3.72
5.03%
interest debt per share
346.63
-
507.36
46.37%
316.32
37.65%
201.70
36.24%
290.15
43.85%
1.05
99.64%
15.84
1,410.19%
5.98
62.25%
inventory turnover
96.79
-
203.23
109.97%
invested capital
-1.01
-
-1.26
24.76%
-1.19
6.09%
-0.67
43.85%
-1.84
176.92%
-0.06
96.65%
0.01
114.47%
0.54
5,938.62%
-3.21
694.40%
market cap
43.11M
-
43.11M
0%
35.23M
18.28%
13.27M
62.33%
4.06M
69.42%
6.49M
60.01%
18.19M
180.03%
15.44M
15.09%
net current asset value
-7.27M
-
-7.71M
6.10%
-2.56M
66.74%
-3.98M
55.11%
-2.65M
33.34%
-2.00M
24.37%
7.57M
477.61%
4.43M
41.53%
-1.50M
133.93%
net debt to ebitda
-0.37
-
-0.34
8.73%
-0.09
73.49%
-0.54
498.50%
-0.13
76.67%
1.57
1,348.99%
1.94
23.35%
0.54
71.86%
0.05
91.35%
net income per share
-688.08
-
-802.97
16.70%
-670.77
16.46%
-253.59
62.19%
-269.77
6.38%
-7.72
97.14%
-32.16
316.72%
-21.90
31.89%
operating cash flow per share
-621.30
-
-672.32
8.21%
-561.17
16.53%
-199.53
64.44%
-100.53
49.62%
-38.41
61.79%
-16.14
57.97%
-18.76
16.22%
payables turnover
1.48
-
0.83
43.76%
1.03
23.26%
0.75
26.58%
0.71
5.20%
0.86
20.47%
receivables turnover
25
-
0.26
98.94%
research and ddevelopement to revenue
60
-
21.07
64.88%
12.39
41.22%
return on tangible assets
-4.60
-
-2.69
41.55%
-3.76
40.13%
-5.83
54.82%
-2.38
59.19%
-0.50
79.05%
-0.98
96.08%
-1.48
51.50%
-2.89
95.22%
revenue per share
1.25
-
2.14
72.00%
5.18
141.59%
roe
2.21
-
2.29
3.60%
4.33
89.25%
1.38
68.23%
4.13
200.38%
0.47
88.70%
-1.35
388.87%
-3.20
137.18%
11.90
471.65%
roic
-173.27
-
-8.01
95.38%
-18.70
133.34%
3.62
119.36%
-1.99
155.07%
2.45
222.78%
-0.76
131.24%
-1.90
148.77%
-4.02
111.41%
sales general and administrative to revenue
56.28
-
115.51
105.24%
27.66
76.05%
shareholders equity per share
-311.32
-
-350.67
12.64%
-154.79
55.86%
-184.22
19.02%
-65.24
64.59%
-16.52
74.68%
23.83
244.26%
6.84
71.28%
stock based compensation to revenue
2.16
-
6.40
196.08%
tangible asset value
-6.33M
-
-7.08M
11.81%
-2.50M
64.74%
-3.92M
57.21%
-2.61M
33.44%
-1.86M
28.87%
7.69M
514.10%
4.50M
41.54%
-1.28M
128.37%
tangible book value per share
-315.71
-
-353.01
11.81%
-155.79
55.87%
-184.79
18.62%
-65.64
64.48%
-16.65
74.63%
23.78
242.80%
6.82
71.33%
working capital
-3.11M
-
-1.42M
54.37%
-2.56M
80.69%
-3.04M
18.76%
-2.56M
15.80%
-1.92M
25.08%
7.63M
497.19%
4.43M
41.98%
-1.44M
132.41%

All numbers in EUR (except ratios and percentages)